This would potentially explain why HIV/TB coinfected patients still display increased HO-1 levels at the end of anti-TB treatment as well as the observed reductions in serum HO-1 in patients on ART compared to ART-naïve individuals. This evidence concerns the gene HMOX1 and tuberculosis.